ZA872877B - Stable aqueous solution of vincristine sulfate - Google Patents
Stable aqueous solution of vincristine sulfateInfo
- Publication number
- ZA872877B ZA872877B ZA872877A ZA872877A ZA872877B ZA 872877 B ZA872877 B ZA 872877B ZA 872877 A ZA872877 A ZA 872877A ZA 872877 A ZA872877 A ZA 872877A ZA 872877 B ZA872877 B ZA 872877B
- Authority
- ZA
- South Africa
- Prior art keywords
- vincristine sulfate
- aqueous solution
- stable aqueous
- solution
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8606030A FR2597750B1 (fr) | 1986-04-25 | 1986-04-25 | Solution aqueuse stable de sulfate de vincristine |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA872877B true ZA872877B (en) | 1987-10-12 |
Family
ID=9334638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA872877A ZA872877B (en) | 1986-04-25 | 1987-04-23 | Stable aqueous solution of vincristine sulfate |
Country Status (10)
Country | Link |
---|---|
US (1) | US4966903A (xx) |
EP (1) | EP0243278B1 (xx) |
JP (1) | JPS62273918A (xx) |
AT (1) | ATE60903T1 (xx) |
CA (1) | CA1303510C (xx) |
DE (1) | DE3768043D1 (xx) |
ES (1) | ES2020671B3 (xx) |
FR (1) | FR2597750B1 (xx) |
GR (1) | GR3001767T3 (xx) |
ZA (1) | ZA872877B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623089B1 (fr) * | 1987-11-13 | 1990-04-27 | Pf Medicament | Composition pharmaceutique pour l'administration parenterale de navelbine |
HU204995B (en) | 1989-11-07 | 1992-03-30 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes |
US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
EP3030624A4 (en) * | 2013-08-07 | 2017-08-02 | Xagenic, Inc. | Microchip structure and treatments for electrochemical detection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1254057A (en) * | 1969-04-24 | 1971-11-17 | Louisette Olivier | Improvements in or relating to therapeutical composition containing vincamine |
US3749784A (en) * | 1972-05-03 | 1973-07-31 | Lilly Co Eli | Psoriasis treatment |
JPS58208222A (ja) * | 1982-05-28 | 1983-12-03 | Japan Found Cancer | 抗腫瘍剤効果増強剤 |
IT1170152B (it) * | 1982-07-19 | 1987-06-03 | Lilly Co Eli | Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi |
US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
-
1986
- 1986-04-25 FR FR8606030A patent/FR2597750B1/fr not_active Expired
-
1987
- 1987-04-23 ZA ZA872877A patent/ZA872877B/xx unknown
- 1987-04-24 EP EP87400960A patent/EP0243278B1/fr not_active Expired - Lifetime
- 1987-04-24 JP JP62100242A patent/JPS62273918A/ja active Pending
- 1987-04-24 DE DE8787400960T patent/DE3768043D1/de not_active Expired - Lifetime
- 1987-04-24 AT AT87400960T patent/ATE60903T1/de not_active IP Right Cessation
- 1987-04-24 CA CA000535495A patent/CA1303510C/fr not_active Expired - Lifetime
- 1987-04-24 ES ES87400960T patent/ES2020671B3/es not_active Expired - Lifetime
-
1988
- 1988-10-13 US US07/257,148 patent/US4966903A/en not_active Expired - Lifetime
-
1991
- 1991-04-11 GR GR91400479T patent/GR3001767T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US4966903A (en) | 1990-10-30 |
FR2597750B1 (fr) | 1989-06-02 |
CA1303510C (fr) | 1992-06-16 |
EP0243278B1 (fr) | 1991-02-20 |
JPS62273918A (ja) | 1987-11-28 |
EP0243278A1 (fr) | 1987-10-28 |
ATE60903T1 (de) | 1991-03-15 |
GR3001767T3 (en) | 1992-11-23 |
DE3768043D1 (de) | 1991-03-28 |
FR2597750A1 (fr) | 1987-10-30 |
ES2020671B3 (es) | 1991-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8603271A1 (es) | Un metodo de producir una composicion de interleuquina-2 | |
AU2755184A (en) | Production of stabilized whey protein product | |
EP0554570A3 (en) | Stable fibrinogen solution | |
IN170138B (xx) | ||
FI873672A (fi) | Kompositioner innehaollande l-3,4-dihydroxifenylalanin. | |
AU5199886A (en) | Mouth rinsing solution | |
SE8505048D0 (sv) | Nutritionsemulsion med syretransporterande egenskaper | |
MX9603278A (es) | Sal compleja de acido fosforico-aminoacido novedosa y composicion aditiva que contiene la sal y utilizada en la comida para mamiferos rumiantes. | |
GR3001767T3 (en) | Stable aqueous solution of vincristine sulfate | |
ES8708220A1 (es) | Procedimiento para la obtencion de halogeno-hidroxi-flavonas | |
IT1239282B (it) | Soluzione acquosa contenente acido cromoglicico e salbutamol, oppure sali farmaceuticamente accettabili | |
DE3480258D1 (en) | Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts | |
GR3005282T3 (xx) | ||
GR3029319T3 (en) | Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity | |
JPS56148291A (en) | Stabilizing agent for enzyme | |
OA07904A (fr) | Composition nutritive de l'acide alpha-cétois un de ses sels. | |
ES2010854A6 (es) | Una composicion de fluido funcional o lubricante. | |
EP0142597A3 (en) | Curative composition for buerger's disease | |
FR2558481B1 (fr) | Procede de preparation de l'acide 4-amino-3-hydroxybutyrique optiquement actif | |
ES2001042A6 (es) | Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos | |
BG60542B2 (en) | Water soluble composition having coccidiostatic effect | |
AU559302B2 (en) | Ammonium and aklylolammonium alkyl sulphate surfactants | |
ES8606248A1 (es) | Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa | |
SE8203692L (en) | Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth | |
JPS6475433A (en) | Remedy for herpes simplex virus infection |